Biologic Drug Quality Assurance to Optimize Her2+ Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar Sb3 (Vol 15, Pg 467, 2020)

AuthID
 P-00S-YPB
5
Author(s)
Lyman, GH
·
Goncalves, J
·
Pivot, X
·
Seo, M
Document Type
Correction
Year published
2020
Published
in TARGETED ONCOLOGY, ISSN: 1776-2596
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000580395600001
Source Identifiers
ISSN: 1776-2596
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas instituições

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service